Bray Capital Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$843K Hold
9,360
0.23% 84
2024
Q3
$925K Sell
9,360
-550
-6% -$54.3K 0.23% 84
2024
Q2
$919K Sell
9,910
-250
-2% -$23.2K 0.23% 81
2024
Q1
$964K Hold
10,160
0.24% 84
2023
Q4
$907K Sell
10,160
-1,170
-10% -$104K 0.25% 84
2023
Q3
$827K Hold
11,330
0.25% 84
2023
Q2
$943K Sell
11,330
-145
-1% -$12.1K 0.28% 81
2023
Q1
$875K Hold
11,475
0.26% 81
2022
Q4
$952K Sell
11,475
-1,465
-11% -$122K 0.3% 78
2022
Q3
$1.03M Hold
12,940
0.32% 77
2022
Q2
$961K Sell
12,940
-630
-5% -$46.8K 0.29% 87
2022
Q1
$1.22M Buy
13,570
+2,460
+22% +$221K 0.31% 75
2021
Q4
$1.24M Sell
11,110
-1,300
-10% -$146K 0.3% 71
2021
Q3
$1.56M Hold
12,410
0.4% 64
2021
Q2
$1.68M Buy
12,410
+445
+4% +$60.2K 0.43% 62
2021
Q1
$1.62M Buy
11,965
+710
+6% +$96.3K 0.45% 63
2020
Q4
$1.58M Buy
11,255
+130
+1% +$18.3K 0.46% 58
2020
Q3
$1.24M Sell
11,125
-15
-0.1% -$1.67K 0.44% 58
2020
Q2
$1.25M Hold
11,140
0.48% 57
2020
Q1
$863K Sell
11,140
-200
-2% -$15.5K 0.4% 62
2019
Q4
$1.08M Hold
11,340
0.38% 66
2019
Q3
$865K Hold
11,340
0.34% 69
2019
Q2
$995K Hold
11,340
0.38% 69
2019
Q1
$1.03M Buy
11,340
+850
+8% +$77K 0.43% 62
2018
Q4
$753K Buy
10,490
+1,855
+21% +$133K 0.38% 65
2018
Q3
$828K Hold
8,635
0.37% 64
2018
Q2
$822K Hold
8,635
0.38% 62
2018
Q1
$758K Hold
8,635
0.35% 63
2017
Q4
$733K Sell
8,635
-6,975
-45% -$592K 0.35% 66
2017
Q3
$1.35M Hold
15,610
0.71% 52
2017
Q2
$1.21M Buy
15,610
+8,525
+120% +$658K 0.66% 54
2017
Q1
$491K Sell
7,085
-560
-7% -$38.8K 0.28% 68
2016
Q4
$453K Buy
+7,645
New +$453K 0.27% 74